Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schell

Showing results (531-540 of 634) with videos related to

Pageof 64
Sort By:
British Journal of Cancer|April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancerDae Won Kim, Elaine Tan, Jun-Min Zhou, et al.
The Plant Journal : for Cell and Molecular Biology|July 24, 1998
Transcription of the Arabidopsis CPD gene, encoding a steroidogenic cytochrome P450, is negatively controlled by brassinosteroidsJ Mathur, G Molnár, S Fujioka, et al.
Molecular Ecology|September 29, 2021
Persistence and expansion of cryptic endangered red wolf genomic ancestry along the American Gulf coastBridgett M vonHoldt, Kristin E Brzeski, Matthew L Aardema, et al.
Blood|August 19, 2006
ABCG2 expression, function, and promoter methylation in human multiple myelomaJoel G Turner, Jana L Gump, Chunchun Zhang, et al.
Glia|June 15, 2010
Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neuronsNader D Halim, Thomas Mcfate, Ahmed Mohyeldin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancerA Stark, B S Hulka, S Joens, et al.
Science (New York, N.Y.)|July 19, 1996
Modification of phytohormone response by a peptide encoded by ENOD40 of legumes and a nonlegumeK van de Sande, K Pawlowski, I Czaja, et al.
Cancer|August 10, 2000
Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trialM A Socinski, J G Rosenman, M J Schell, et al.
Clinical Genitourinary Cancer|March 7, 2022
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal CancerJonathan Chatzkel, Michael J Schell, Jad Chahoud, et al.
International Journal of Cancer|December 15, 2010
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytomaS Tariq Mahmood, Samuel Agresta, Carlos E Vigil, et al.
Pageof 64

Showing results (531-540 of 634) with videos related to

Sort By:
Pageof 64
British Journal of Cancer|April 8, 2021
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancerDae Won Kim, Elaine Tan, Jun-Min Zhou, et al.
The Plant Journal : for Cell and Molecular Biology|July 24, 1998
Transcription of the Arabidopsis CPD gene, encoding a steroidogenic cytochrome P450, is negatively controlled by brassinosteroidsJ Mathur, G Molnár, S Fujioka, et al.
Molecular Ecology|September 29, 2021
Persistence and expansion of cryptic endangered red wolf genomic ancestry along the American Gulf coastBridgett M vonHoldt, Kristin E Brzeski, Matthew L Aardema, et al.
Blood|August 19, 2006
ABCG2 expression, function, and promoter methylation in human multiple myelomaJoel G Turner, Jana L Gump, Chunchun Zhang, et al.
Glia|June 15, 2010
Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neuronsNader D Halim, Thomas Mcfate, Ahmed Mohyeldin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2000
HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancerA Stark, B S Hulka, S Joens, et al.
Science (New York, N.Y.)|July 19, 1996
Modification of phytohormone response by a peptide encoded by ENOD40 of legumes and a nonlegumeK van de Sande, K Pawlowski, I Czaja, et al.
Cancer|August 10, 2000
Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trialM A Socinski, J G Rosenman, M J Schell, et al.
Clinical Genitourinary Cancer|March 7, 2022
Coordinated Pembrolizumab and High Dose IL-2 (5-in-a-Row Schedule) for Therapy of Metastatic Clear Cell Renal CancerJonathan Chatzkel, Michael J Schell, Jad Chahoud, et al.
International Journal of Cancer|December 15, 2010
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytomaS Tariq Mahmood, Samuel Agresta, Carlos E Vigil, et al.
Pageof 64